Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Haas

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Kidney International|March 13, 2003
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantationMartin Haas, Zdenka Leko-Mohr, Paul Roschger, et al.
Plos One|March 30, 2017
Increased trefoil factor 2 levels in patients with chronic kidney diseaseDiana Lebherz-Eichinger, Bianca Tudor, Hendrik J Ankersmit, et al.
Plos One|January 4, 2014
Tyrosine phosphorylation allows integration of multiple signaling inputs by IKKβApril N Meyer, Kristine A Drafahl, Christopher W McAndrew, et al.
Bone|November 17, 2010
Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age)Georg Goliasch, Hermann Blessberger, Danyel Azar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2011
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patientsDaniel Cejka, Agnes Jäger-Lansky, Heidi Kieweg, et al.
Pediatric Research|December 28, 2012
The CD95/CD95L pathway is involved in phagocytosis-induced cell death of monocytes and may account for sustained inflammation in neonatesChristian Gille, Stephan Dreschers, Anja Leiber, et al.
Kidney International|August 17, 2016
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney diseaseDaniel Cejka, Diego Parada-Rodriguez, Stefanie Pichler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 2011
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney diseaseDiana Lebherz-Eichinger, Hendrik J Ankersmit, Stefan Hacker, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2011
Increased total cytokeratin-18 serum and urine levels in chronic kidney diseaseGeorg A Roth, Diana Lebherz-Eichinger, Hendrik Jan Ankersmit, et al.
Wiener Klinische Wochenschrift|June 14, 2002
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot studyMartin Haas, Gert Mayer, Gerhard Wirnsberger, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Kidney International|March 13, 2003
Zoledronic acid to prevent bone loss in the first 6 months after renal transplantationMartin Haas, Zdenka Leko-Mohr, Paul Roschger, et al.
Plos One|March 30, 2017
Increased trefoil factor 2 levels in patients with chronic kidney diseaseDiana Lebherz-Eichinger, Bianca Tudor, Hendrik J Ankersmit, et al.
Plos One|January 4, 2014
Tyrosine phosphorylation allows integration of multiple signaling inputs by IKKβApril N Meyer, Kristine A Drafahl, Christopher W McAndrew, et al.
Bone|November 17, 2010
Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age)Georg Goliasch, Hermann Blessberger, Danyel Azar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2011
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patientsDaniel Cejka, Agnes Jäger-Lansky, Heidi Kieweg, et al.
Pediatric Research|December 28, 2012
The CD95/CD95L pathway is involved in phagocytosis-induced cell death of monocytes and may account for sustained inflammation in neonatesChristian Gille, Stephan Dreschers, Anja Leiber, et al.
Kidney International|August 17, 2016
Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney diseaseDaniel Cejka, Diego Parada-Rodriguez, Stefanie Pichler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 2011
HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney diseaseDiana Lebherz-Eichinger, Hendrik J Ankersmit, Stefan Hacker, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2011
Increased total cytokeratin-18 serum and urine levels in chronic kidney diseaseGeorg A Roth, Diana Lebherz-Eichinger, Hendrik Jan Ankersmit, et al.
Wiener Klinische Wochenschrift|June 14, 2002
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot studyMartin Haas, Gert Mayer, Gerhard Wirnsberger, et al.
Pageof 8